glp-1 drugs tirzepatide Menopause Hormone Therapy May Boost Drug Benefits How GLP-1 medications are transforming
Description
( I ) Quantification of glucose oxidation in caECs pretreated with 100 nM GLP-1(2836) or scrambled control for 20 minutes
*Correspondence: Salvatore Corrao, [email protected]
Fatty acids from dietary fats may also boost GLP-1 release
For semaglutide , a phase 2 trial published in the New England Journal of Medicine (2021) examined daily semaglutide 0.4 mg in NASH patients and found that 59% achieved NASH resolution compared to 17% with placebo
In the 12 mg group, 18.2% of patients discontinued treatment due to adverse events
